Trial Profile
Effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and renal dysfunction.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Jan 2018
Price :
$35
*
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure; Kidney disorders
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 09 Jan 2018 New trial record